A BILL 
To provide grants to better understand and reduce 
gestational diabetes, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Gestational Diabetes 
4
Act of 2019’’ or the ‘‘GEDI Act’’. 
5
SEC. 2. GESTATIONAL DIABETES. 
6
Part B of title III of the Public Health Service Act 
7
(42 U.S.C. 243 et seq.) is amended by inserting after sec-
8
tion 317H the following: 
9
00:47 Jun 14, 2019
H3109
2 
•HR 3109 IH
‘‘SEC. 317H–1. GESTATIONAL DIABETES. 
1
‘‘(a) UNDERSTANDING
AND MONITORING GESTA-
2
TIONAL DIABETES.— 
3
‘‘(1) IN
GENERAL.—The Secretary, acting 
4
through the Director of the Centers for Disease 
5
Control and Prevention, in consultation with the Di-
6
abetes Mellitus Interagency Coordinating Committee 
7
established under section 429 and representatives of 
8
appropriate national health organizations, shall de-
9
velop a multisite gestational diabetes research 
10
project within the diabetes program of the Centers 
11
for Disease Control and Prevention to expand and 
12
enhance surveillance data and public health research 
13
on gestational diabetes. 
14
‘‘(2) AREAS TO BE ADDRESSED.—The research 
15
project developed under paragraph (1) shall ad-
16
dress— 
17
‘‘(A) procedures to establish accurate and 
18
efficient systems for the collection of gestational 
19
diabetes data within each State and common-
20
wealth, territory, or possession of the United 
21
States; 
22
‘‘(B) the progress of collaborative activities 
23
with the National Vital Statistics System, the 
24
National Center for Health Statistics, and 
25
State health departments with respect to the 
26
00:47 Jun 14, 2019
H3109
3 
•HR 3109 IH
standard birth certificate, in order to improve 
1
surveillance of gestational diabetes; 
2
‘‘(C) postpartum methods of tracking 
3
women with gestational diabetes after delivery 
4
as well as targeted interventions proven to 
5
lower the incidence of type 2 diabetes in that 
6
population; 
7
‘‘(D) variations in the distribution of diag-
8
nosed and undiagnosed gestational diabetes, 
9
and of impaired fasting glucose tolerance and 
10
impaired fasting glucose, within and among 
11
groups of women; and 
12
‘‘(E) factors and culturally sensitive inter-
13
ventions that influence risks and reduce the in-
14
cidence of gestational diabetes and related com-
15
plications during childbirth, including cultural, 
16
behavioral, racial, ethnic, geographic, demo-
17
graphic, socioeconomic, and genetic factors. 
18
‘‘(3) REPORT.—Not later than 2 years after the 
19
date of the enactment of this section, and annually 
20
thereafter, the Secretary shall generate a report on 
21
the findings and recommendations of the research 
22
project including prevalence of gestational diabetes 
23
in the multisite area and disseminate the report to 
24
the appropriate Federal and non-Federal agencies. 
25
00:47 Jun 14, 2019
H3109
4 
•HR 3109 IH
‘‘(b) EXPANSION OF GESTATIONAL DIABETES RE-
1
SEARCH.— 
2
‘‘(1) IN GENERAL.—The Secretary shall expand 
3
and intensify public health research regarding gesta-
4
tional diabetes. Such research may include— 
5
‘‘(A) developing and testing novel ap-
6
proaches for improving postpartum diabetes 
7
testing or screening and for preventing type 2 
8
diabetes in women with a history of gestational 
9
diabetes; and 
10
‘‘(B) conducting public health research to 
11
further understanding of the epidemiologic, 
12
socioenvironmental, behavioral, translation, and 
13
biomedical factors and health systems that in-
14
fluence the risk of gestational diabetes and the 
15
development of type 2 diabetes in women with 
16
a history of gestational diabetes. 
17
‘‘(2) AUTHORIZATION
OF
APPROPRIATIONS.— 
18
There is authorized to be appropriated to carry out 
19
this subsection $5,000,000 for each of fiscal years 
20
2020 through 2024. 
21
‘‘(c) DEMONSTRATION GRANTS TO LOWER
THE 
22
RATE OF GESTATIONAL DIABETES.— 
23
‘‘(1) IN
GENERAL.—The Secretary, acting 
24
through the Director of the Centers for Disease 
25
00:47 Jun 14, 2019
H3109
5 
•HR 3109 IH
Control and Prevention, shall award grants, on a 
1
competitive basis, to eligible entities for demonstra-
2
tion projects that implement evidence-based inter-
3
ventions to reduce the incidence of gestational diabe-
4
tes, the recurrence of gestational diabetes in subse-
5
quent pregnancies, and the development of type 2 di-
6
abetes in women with a history of gestational diabe-
7
tes. 
8
‘‘(2) PRIORITY.—In making grants under this 
9
subsection, the Secretary shall give priority to 
10
projects focusing on— 
11
‘‘(A) helping women who have 1 or more 
12
risk factors for developing gestational diabetes; 
13
‘‘(B) working with women with a history of 
14
gestational diabetes during a previous preg-
15
nancy; 
16
‘‘(C) providing postpartum care for women 
17
with gestational diabetes; 
18
‘‘(D) tracking cases where women with a 
19
history of gestational diabetes developed type 2 
20
diabetes; 
21
‘‘(E) educating mothers with a history of 
22
gestational diabetes about the increased risk of 
23
their child developing diabetes; 
24
00:47 Jun 14, 2019
H3109
6 
•HR 3109 IH
‘‘(F) working to prevent gestational diabe-
1
tes and prevent or delay the development of 
2
type 2 diabetes in women with a history of ges-
3
tational diabetes; and 
4
‘‘(G) achieving outcomes designed to assess 
5
the efficacy and cost-effectiveness of interven-
6
tions that can inform decisions on long-term 
7
sustainability, including third-party reimburse-
8
ment. 
9
‘‘(3) APPLICATION.—An eligible entity desiring 
10
to receive a grant under this subsection shall submit 
11
to the Secretary— 
12
‘‘(A) an application at such time, in such 
13
manner, and containing such information as the 
14
Secretary may require; and 
15
‘‘(B) a plan to— 
16
‘‘(i) lower the rate of gestational dia-
17
betes during pregnancy; or 
18
‘‘(ii) develop methods of tracking 
19
women with a history of gestational diabe-
20
tes and develop effective interventions to 
21
lower the incidence of the recurrence of 
22
gestational diabetes in subsequent preg-
23
nancies and the development of type 2 dia-
24
betes. 
25
00:47 Jun 14, 2019
H3109
7 
•HR 3109 IH
‘‘(4) USES OF FUNDS.—An eligible entity re-
1
ceiving a grant under this subsection shall use the 
2
grant funds to carry out demonstration projects de-
3
scribed in paragraph (1), including— 
4
‘‘(A) expanding community-based health 
5
promotion education, activities, and incentives 
6
focused on the prevention of gestational diabe-
7
tes and development of type 2 diabetes in 
8
women with a history of gestational diabetes; 
9
‘‘(B) aiding State- and tribal-based diabe-
10
tes prevention and control programs to collect, 
11
analyze, disseminate, and report surveillance 
12
data on women with, and at risk for, gesta-
13
tional diabetes, the recurrence of gestational di-
14
abetes in subsequent pregnancies, and, for 
15
women with a history of gestational diabetes, 
16
the development of type 2 diabetes; and 
17
‘‘(C) training and encouraging health care 
18
providers— 
19
‘‘(i) to promote risk assessment, high- 
20
quality care, and self-management for ges-
21
tational diabetes and the recurrence of ges-
22
tational diabetes in subsequent preg-
23
nancies; and 
24
00:47 Jun 14, 2019
H3109
8 
•HR 3109 IH
‘‘(ii) to prevent the development of 
1
type 2 diabetes in women with a history of 
2
gestational diabetes, and its complications 
3
in the practice settings of the health care 
4
providers. 
5
‘‘(5) REPORT.—Not later than 4 years after the 
6
date of the enactment of this section, the Secretary 
7
shall prepare and submit to the Congress a report 
8
concerning the results of the demonstration projects 
9
conducted through the grants awarded under this 
10
subsection. 
11
‘‘(6) DEFINITION
OF
ELIGIBLE
ENTITY.—In 
12
this subsection, the term ‘eligible entity’ means a 
13
nonprofit organization (such as a nonprofit academic 
14
center or community health center) or a State, trib-
15
al, or local health agency. 
16
‘‘(7) AUTHORIZATION
OF
APPROPRIATIONS.— 
17
There is authorized to be appropriated to carry out 
18
this subsection $5,000,000 for each of fiscal years 
19
2020 through 2024. 
20
‘‘(d) POSTPARTUM FOLLOW-UP REGARDING GESTA-
21
TIONAL DIABETES.—The Secretary, acting through the 
22
Director of the Centers for Disease Control and Preven-
23
tion, shall work with the State- and tribal-based diabetes 
24
prevention and control programs assisted by the Centers 
25
00:47 Jun 14, 2019
H3109
9 
•HR 3109 IH
to encourage postpartum follow-up after gestational diabe-
1
tes, as medically appropriate, for the purpose of reducing 
2
the incidence of gestational diabetes, the recurrence of 
3
gestational diabetes in subsequent pregnancies, the devel-
4
opment of type 2 diabetes in women with a history of ges-
5
tational diabetes, and related complications.’’. 
6
Æ 
00:47 Jun 14, 2019
H3109
